Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lukas Graf

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Diagnostics (Basel, Switzerland)|June 28, 2023
Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban CalibratorAnnika Burger, Jan-Dirk Studt, Adriana Mendez, et al.
Cancers|August 28, 2025
Prognostic Impact of the AML60+ Score for Elderly Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents: A Retrospective Multicentric AnalysisVerena Petermichl, Stefan Fuchs, Matthias Weber, et al.
Frontiers in Cardiovascular Medicine|April 4, 2022
Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional StudyTamana Meihandoest, Jan-Dirk Studt, Adriana Mendez, et al.
Journal of Clinical Medicine|November 13, 2025
Toward Artificial Intelligence in Oncology and Cardiology: A Narrative Review of Systems, Challenges, and OpportunitiesVisar Vela, Ali Yasin Sonay, Perparim Limani, et al.
BMC Microbiology|January 4, 2024
Novel Organism Verification and Analysis (NOVA) study: identification of 35 clinical isolates representing potentially novel bacterial taxa using a pipeline based on whole genome sequencingVeronika Muigg, Helena M B Seth-Smith, Kai-Manuel Adam, et al.
Blood Advances|August 4, 2025
Outcomes of Patients with Suspected Heparin-Induced Thrombocytopenia in a Contemporary Multicenter CohortHenning Nilius, Ekaterina Sinitsa, Jan-Dirk Studt, et al.
Journal of Thrombosis and Haemostasis : JTH|May 29, 2023
Limited concordance of heparin/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT studyAngelika Hammerer-Lercher, Henning Nilius, Jan-Dirk Studt, et al.
Swiss Medical Weekly|April 25, 2020
Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in SwitzerlandLorenzo Alberio, Anne Angelillo-Scherrer, Lars Asmis, et al.
Swiss Medical Weekly|April 12, 2020
Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party HemostasisAlessandro Casini, Lorenzo Alberio, Anne Angelillo-Scherrer, et al.
Journal of Thrombosis and Haemostasis : JTH|November 13, 2024
The dynamic range of immunoassays for heparin-induced thrombocytopeniaHenning Nilius, Samra Naas, Jan-Dirk Studt, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Diagnostics (Basel, Switzerland)|June 28, 2023
Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban CalibratorAnnika Burger, Jan-Dirk Studt, Adriana Mendez, et al.
Cancers|August 28, 2025
Prognostic Impact of the AML60+ Score for Elderly Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents: A Retrospective Multicentric AnalysisVerena Petermichl, Stefan Fuchs, Matthias Weber, et al.
Frontiers in Cardiovascular Medicine|April 4, 2022
Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional StudyTamana Meihandoest, Jan-Dirk Studt, Adriana Mendez, et al.
Journal of Clinical Medicine|November 13, 2025
Toward Artificial Intelligence in Oncology and Cardiology: A Narrative Review of Systems, Challenges, and OpportunitiesVisar Vela, Ali Yasin Sonay, Perparim Limani, et al.
BMC Microbiology|January 4, 2024
Novel Organism Verification and Analysis (NOVA) study: identification of 35 clinical isolates representing potentially novel bacterial taxa using a pipeline based on whole genome sequencingVeronika Muigg, Helena M B Seth-Smith, Kai-Manuel Adam, et al.
Blood Advances|August 4, 2025
Outcomes of Patients with Suspected Heparin-Induced Thrombocytopenia in a Contemporary Multicenter CohortHenning Nilius, Ekaterina Sinitsa, Jan-Dirk Studt, et al.
Journal of Thrombosis and Haemostasis : JTH|May 29, 2023
Limited concordance of heparin/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT studyAngelika Hammerer-Lercher, Henning Nilius, Jan-Dirk Studt, et al.
Swiss Medical Weekly|April 25, 2020
Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in SwitzerlandLorenzo Alberio, Anne Angelillo-Scherrer, Lars Asmis, et al.
Swiss Medical Weekly|April 12, 2020
Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party HemostasisAlessandro Casini, Lorenzo Alberio, Anne Angelillo-Scherrer, et al.
Journal of Thrombosis and Haemostasis : JTH|November 13, 2024
The dynamic range of immunoassays for heparin-induced thrombocytopeniaHenning Nilius, Samra Naas, Jan-Dirk Studt, et al.
Pageof 7